Idiopathic Inflammatory Myopathies Clinical Trials

58 clinical trials for Idiopathic Inflammatory Myopathies across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) — RECRUITING · PHASE1
• A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases — RECRUITING · PHASE1
• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. — RECRUITING · PHASE2
• Biomarkers in Autoimmune Disease of Nervous System — RECRUITING
• A Study of AZD0120 in Autoimmune Diseases — RECRUITING · PHASE1
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis. — RECRUITING · PHASE1
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases — RECRUITING · PHASE4
• MTS109 in Patients With Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Adult Autoimmune Myopathies (MAIA) — RECRUITING · NA
• EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases — RECRUITING
• Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases — RECRUITING · PHASE2
• Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. — RECRUITING · PHASE1
• A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease — RECRUITING · PHASE1
• Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases — RECRUITING · PHASE1
• A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) — RECRUITING · PHASE1
• Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis — RECRUITING · PHASE1
• An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases — RECRUITING · PHASE1
• Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases — RECRUITING · PHASE1
• AYLo - AutoimmunitY and Loss of y — RECRUITING
• Sport in patients with neuromuscular diseases — RECRUITING
• Optimizing Treatment on Idiopathic Inflammatory Myopathies — RECRUITING
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System — RECRUITING · PHASE1
• Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) — RECRUITING · PHASE1
• Correlation of translational molecular imaging using multispectral optoacoustic tomography (MSOT) with histopathological changes in myopathies — RECRUITING
• Multispectral Optoacoustic Tomography (MSOT) as a non-invasive biomarker in diagnostics and follow-up of myopathies — RECRUITING
• Study of Families With Twins or Siblings Discordant for Rheumatic Disorders — COMPLETED
• Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research — NOT_YET_RECRUITING
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases — COMPLETED
• CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic Inflammatory Myopathies — WITHDRAWN
• Phase 2 Study of Rapcabtagene Autoleucel in Myositis — ACTIVE_NOT_RECRUITING · PHASE2
• PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS — ACTIVE_NOT_RECRUITING
• A Study of BEN301 Injection in theTreatment of Autoimmune Diseases — SUSPENDED · PHASE1
• Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases — ACTIVE_NOT_RECRUITING · PHASE4
• Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders — COMPLETED · NA
• Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders — COMPLETED · NA
• YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 — ACTIVE_NOT_RECRUITING · PHASE1
• Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases — SUSPENDED · PHASE1
• Tongji NADs Cohort — NOT_YET_RECRUITING
• A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases — ACTIVE_NOT_RECRUITING · PHASE1
• Neuromuscular disorders as emergencies in the intensive care setting - A retrospective cohort study on predictors of clinical outcome — OTHER
• Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV — NOT_YET_RECRUITING · PHASE1
• Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies — TERMINATED · PHASE1
• Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis — COMPLETED · PHASE2
• Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases — OTHER · PHASE1
• Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases — OTHER · NA
• Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases — OTHER · PHASE1
• Clinical Study Cohort of Idiopathic Inflammatory Myositis — NOT_YET_RECRUITING

Refine this search